Related Topics News -

     
 Detail   |   Print 
     
中國上半年創新藥對外授權交易總額增至1,100億美元 再創新高
2026-07-13T  
《大行》麥格理升百濟神州目標價至257元 重申「跑贏大市」評級
2026-07-13T  
恆指公司:恆生生物科技指數自6月低位反彈逾17% 成分股加大回購力度
2026-07-10T  
新版國家基本藥物目錄發布 增加覆蓋惠及基層
2026-07-09T  
《大行》瑞銀微降百濟神州目標價至456美元重申「買入」 百悅澤提供MCL潛在無化療選項
2026-07-02T  
百濟神州:百悅澤3期臨床研究MANGROVE取積極結果
2026-07-02T  
百濟神州須補繳所得稅及滯納金逾4億人民幣
2026-06-29T  
易方達港交所科技100 ETF本周五上市
2026-06-22T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.